SearchDictionaryMobileLogin

Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma.

AbstractBACKGROUND: Photodynamic therapy (PDT) for basal cell carcinoma (BCC) is a treatment modality that is increasingly used in dermato-oncology. Currently, 2 topical photosensitizers, 5-aminolevulinate (ALA) and methyl aminolevulinate (MAL) are widely used, but their efficacy in BCC has not yet been compared in a clinical setting. OBJECTIVE: To evaluate the effect, degree of pain, and costs of ALA-PDT versus MAL-PDT in nodular BCC (nBCC). METHODS: Patients suffering from BCC were randomly assigned to either ALA-PDT (n=22) or MAL-PDT (n=21) in a pilot study. In each group, half of the tumors were debulked prior to PDT. Eight weeks after treatment, the therapeutic outcome was checked histologically. Pain scores were assessed using a visual analogue scale. RESULTS: Residual tumor tissue was detected in 6 BCCs of each study group. No significant difference between ALA-PDT and MAL-PDT was found with regard to therapeutic efficacy and pain scores. Of note, however, the costs of MAL-PDT were 6-fold higher than those of ALA-PDT. CONCLUSIONS: In this study we did not observe any differences in short-term efficacy between ALA-PDT and MAL-PDT. Therefore, both ALA and MAL can be equally recommended as topical photosensitizers in PDT.
AuthorsDaniëlle I Kuijpers, Monique R Thissen, Carleine A Thissen, Martino H Neumann (Affiliation: Department of Dermatology, University Hospital Maastricht, Maastricht, The Netherlands. dku at sder.azm.nl)
JournalJournal of drugs in dermatology : JDD (J Drugs Dermatol) 2006 Jul-Aug Vol. 5 Issue 7 Pg. 642-5 ISSN: 1545-9616 United States
PMID16865869 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Photosensitizing Agents
  • Aminolevulinic Acid
Topics
  • Administration, Topical
  • Aminolevulinic Acid (administration & dosage, analogs & derivatives, therapeutic use)
  • Carcinoma, Basal Cell (drug therapy)
  • Humans
  • Pain Measurement
  • Photochemotherapy
  • Photosensitizing Agents (therapeutic use)
  • Pilot Projects
  • Skin Neoplasms (drug therapy)
  • Treatment Outcome